Navigation Links
ViroPharma To Host Investor Day
Date:3/16/2010

EXTON, Pa., March 16 /PRNewswire-FirstCall/ -- ViroPharma Incorporated (Nasdaq: VPHM) announced today that the company will provide a live audio webcast of its investor day event, focusing on Cinryze growth opportunities on Friday, March 19, 2010.  Lectures will be provided by a number of ViroPharma representatives.

The investor day, entitled "Cinryze: Expanding the Global Opportunity," will be held from 9:00 A.M. until NOON Eastern Time on Friday, March 19, 2010.  Among the topics ViroPharma will discuss are plans for furthering Cinryze growth in the U.S. HAE prophylaxis market, regulatory timelines and pre-launch planning for Cinryze in the European Union, global expansion opportunities beyond U.S. and E.U. and initial development plans for potential therapeutic uses and modes of administration.

"We are thrilled to be in position to not only provide continued growth with Cinryze here in the United States for HAE, but also moving ahead on various opportunities to grow the product both in HAE worldwide and in other conditions as well," commented Vin Milano, ViroPharma's president and chief executive officer. "We look forward to this event and sharing our plans with investors as they can begin to
'/>"/>

SOURCE ViroPharma Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. ViroPharma to Present at Three Upcoming Healthcare Conferences
2. ViroPharma to Present at the Natixis Bleichroeder Conference
3. ViroPharma To Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
4. ViroPharma to Release 2008 First Quarter Financial Results on April 30, 2008
5. ViroPharma Announces Discontinuation of HCV-796 Development
6. ViroPharma Announces Completion of Enrollment in Phase 3 Study of Maribavir in Stem Cell Transplant Patients
7. ViroPharma Incorporated Completes Acquisition of Lev Pharmaceuticals
8. ViroPharma Announces Presentation of Cinryze(TM) Data in Acute Treatment of Hereditary Angioedema
9. ViroPharma Announces Discontinuation of Maribavir Phase 3 Study in Liver Transplant Patients
10. ViroPharma Submits Comments on Vancocin(R) Draft Bioequivalence Guidance
11. ViroPharma Incorporated Reports Third Quarter 2009 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... YORK , May 5, 2015  IBM Watson ... is collaborating with more than a dozen leading cancer ... and personalize treatment options for their patients. The institutes ... capabilities to reduce from weeks to minutes the ability ... and gather relevant information from medical literature to personalize ...
(Date:5/5/2015)... May 5, 2015  The preclinical contract research organization ... testing of drugs and safety testing of medical devices, ... of Preclinical Studies, presented at this week,s annual meeting ... (ARVO) in Denver, CO. The ... of a Novel, Cross-Linked, Bio-Absorbable Carboxymethyl Hyaluronic Acid (CMHA) ...
(Date:5/5/2015)...  American Laboratory Trading, Inc. (ALT), the leading provider ... veteran Anggie Becorest as their new Senior ... out of the company,s San Diego ... company,s west coast operations, diversifying the company,s offerings, and ... been the leader in the refurbished lab equipment market ...
Breaking Medicine Technology:Clinicians Tap Watson to Accelerate DNA Analysis and Inform Personalized Treatment Options for Patients 2Clinicians Tap Watson to Accelerate DNA Analysis and Inform Personalized Treatment Options for Patients 3Clinicians Tap Watson to Accelerate DNA Analysis and Inform Personalized Treatment Options for Patients 4Clinicians Tap Watson to Accelerate DNA Analysis and Inform Personalized Treatment Options for Patients 5Clinicians Tap Watson to Accelerate DNA Analysis and Inform Personalized Treatment Options for Patients 6Dr. Glen Gum of Absorption Systems Presents at The Association for Research in Vision and Ophthalmology (ARVO) Meeting 2Dr. Glen Gum of Absorption Systems Presents at The Association for Research in Vision and Ophthalmology (ARVO) Meeting 3ALT Names Anggie Becorest Senior Vice President of Business Development 2
... International, Inc. (NYSE: VRX ) (TSX: VRX) ... its wholly owned indirect subsidiary, launched its offer of ... notes (the "Notes"). The Notes will not ... amended (the "Securities Act"), or any state securities law ...
... ALISO VIEJO, Calif., Feb. 3, 2011 A VANIR ... reported unaudited financial results for the three months ended December 31, ... reported a net loss of $12.1 million, or $0.11 loss per ... loss per share, for the same period in fiscal 2010. Net ...
Cached Medicine Technology:Valeant Launches Senior Notes Offering 2Valeant Launches Senior Notes Offering 3AVANIR Pharmaceuticals Announces Fiscal 2011 First Quarter Financial Results 2AVANIR Pharmaceuticals Announces Fiscal 2011 First Quarter Financial Results 3AVANIR Pharmaceuticals Announces Fiscal 2011 First Quarter Financial Results 4AVANIR Pharmaceuticals Announces Fiscal 2011 First Quarter Financial Results 5AVANIR Pharmaceuticals Announces Fiscal 2011 First Quarter Financial Results 6
(Date:5/5/2015)... 2015 AxoGen, Inc. (NASDAQ: AXGN), ... $1.6 billion peripheral nerve repair market, reported record revenue ... 31, 2015 compared to $3.14 million in the year-ago ... our proprietary portfolio of nerve repair products - ... Protector – and our solid sales execution delivered another ...
(Date:5/5/2015)... The global lab automation market is expected ... in 2014, at an estimated CAGR of 6.7% from ... market on the basis of equipment and software, application, ... basis of application, Lab Automation Market is classified into ... Drug discovery is a major application of the lab ...
(Date:5/5/2015)... 2015 Viverae®, a health management ... a leading multinational developer, manufacturer and marketer of ... vascular, urology, oncology and surgical specialty products, as ... The Vanguard Award recognizes outstanding achievement in the ... Viverae’s significant client base. , Viverae reviewed the ...
(Date:5/5/2015)... Dr. Patricia George knows all too well the debilitating ... hypertension specialist at the University of Pittsburgh Medical Center ... initial idea entered her mind for Team PHenomenal Hope. ... the 2010 PHA International Conference,” George recalled. “The speakers ... their climb up Mt. Kilimanjaro and I remember thinking ...
(Date:5/5/2015)... (PRWEB) May 05, 2015 In a April ... The Herald-Times , the Missouri State Highway Patrol (MSHP) ... Methamphetamine production or use for the second year in a ... to the FBI, reported 1,469 incidents in 2014 alone, around ... only around 2% of the US Population calls Indiana home, ...
Breaking Medicine News(10 mins):Health News:AxoGen, Inc. Reports 58% Year-Over-Year Revenue Growth for the 2015 First Quarter 2Health News:AxoGen, Inc. Reports 58% Year-Over-Year Revenue Growth for the 2015 First Quarter 3Health News:AxoGen, Inc. Reports 58% Year-Over-Year Revenue Growth for the 2015 First Quarter 4Health News:Global Lab Automation Market Forecast to 2020: Research Based on Equipment & Software, Applications, Type of Automation and End Users 2Health News:Global Lab Automation Market Forecast to 2020: Research Based on Equipment & Software, Applications, Type of Automation and End Users 3Health News:Global Lab Automation Market Forecast to 2020: Research Based on Equipment & Software, Applications, Type of Automation and End Users 4Health News:Global Lab Automation Market Forecast to 2020: Research Based on Equipment & Software, Applications, Type of Automation and End Users 5Health News:Viverae® Honors C. R. Bard, Inc. with 2015 Vanguard Award 2Health News:World PH Day: Team PHenomenal Hope Races to Spread the Word about Pulmonary Hypertension 2Health News:A Forever Recovery Releases New Information on the Epidemic Rise Of Methamphetamine Abuse in Midwest America 2
... 17 Zargis Medical Corp., a spin-off from Siemens Corporate Research ... Corp. (Nasdaq: SPDE ), announced today it has received ... Signal X6(TM) device. Zargis also announced the delivery of seven ... Department of Defense medical facilities. , , Signal ...
... , CHICAGO, Sept. 17 Today, Scott Lee Cohen, ... statewide "Listening Tour." Cohen embarked on Monday, September 14, 2009 from his ... than 40 planned meetings with elected officials and community leaders throughout the ... include:, Winnebago County; Rockford, IL; ...
... ... Novartis Oncology was conducted independently for CURE magazine among 1,365 of its readers living with ... ... -- A new national survey shows that nearly one in three patients with rare cancers ...
... , PITTSBURGH, Sept. 17 ... solutions for individuals with speech, language and learning disabilities, today ... the Year award from Microsoft Corp. This award recognizes ... Microsoft software in their products. , , ...
... , , , , ... SMTS ) today reported net revenues of $12.5 million for the third quarter ... same period of 2008. For the nine months ended August 31, 2009, ... , U.S. net revenues increased 10 percent to $10.4 million from ...
... , OVERLAND PARK, Kan., Sept. 17 Sunlight Saunas(TM) ... of industry firsts, and announce the winner of its 10th Anniversary ... (Photo: http://www.newscom.com/cgi-bin/prnh/20090917/CG77208 ) , , During its ... carbon heating technology to the market. Unlike conventional saunas that use ...
Cached Medicine News:Health News:Zargis Receives FDA Clearance for Signal X6 Telemedicine Device; OK Allows Delivery to US Army 2Health News:Cohen Launches Second Statewide Tour 2Health News:New Survey Highlights the Challenges of People Living with Rare Cancer 2Health News:New Survey Highlights the Challenges of People Living with Rare Cancer 3Health News:DynaVox Mayer-Johnson Receives Microsoft Award 2Health News:Somanetics Reports Financial Results for the Third Quarter of Fiscal 2009 2Health News:Somanetics Reports Financial Results for the Third Quarter of Fiscal 2009 3Health News:Somanetics Reports Financial Results for the Third Quarter of Fiscal 2009 4Health News:Somanetics Reports Financial Results for the Third Quarter of Fiscal 2009 5Health News:Somanetics Reports Financial Results for the Third Quarter of Fiscal 2009 6Health News:Somanetics Reports Financial Results for the Third Quarter of Fiscal 2009 7Health News:Somanetics Reports Financial Results for the Third Quarter of Fiscal 2009 8Health News:Somanetics Reports Financial Results for the Third Quarter of Fiscal 2009 9Health News:Sunlight Saunas Celebrates 10 Years of Industry Firsts, and Announces 10th Anniversary Sweepstakes Winner 2
QualCraft™ Radiation-Reducing Eyewear is 50% lighter than other protective eyewear. Manufactured for the ultimate combination of comfort, function, and protection....
Clip-On Glasses clip onto regular eyewear frames. Plano (nonprescription) only. Will not fit over high-plus or high-minus presciptions, or over glasses with thick frames. Black wire frames. Wt. 63 g....
... manufactures standard and custom shields and barriers for ... low level or high level radiation shielding, we ... pure lead, lead acrylic, lead glass, lead vinyl ... We can offer shielding from 1/32" thick to ...
Height-Adjustable Mobile X-ray Barrier lets you get close to your patient during special procedures like cardiac cath. 24"H x 36"W viewing panel shields the upper body of one or two people and swivel...
Medicine Products: